Cannabinoid-Like Pharmaceuticals
Non-intoxicating Therapeutic Potential
Cannabinoid-inspired compounds have shown promise across pain, inflammation, and metabolic indications.
However, psychoactivity, regulatory complexity, and manufacturing limitations have restricted the usefulness of many of these naturally occurring molecules.
Expanding What Chemistry Can Reach
The eXoZymes platform enables the creation of non-intoxicating, optimized cannabinoid-like analogs that are difficult or impossible to access through conventional chemistry.
Cell-free production allows rapid exploration of chemical space while maintaining precise control over structure, purity, and scalability.
A Portfolio-Based Strategy
Rather than relying on a single molecule, this program is structured as a diversified portfolio.
Each candidate can pursue multiple commercialization pathways - licensing, co-development, or spin-out formation - creating flexibility and asymmetric upside.